Found 8 matching trials
Vaccine for Patients With Newly Diagnosed or Recurrent Low-Grade Glioma
PHASE2The primary purpose of this phase II clinical trial is to determine the saf...
Location
Jonsson Comprehensive Cancer Center
PEP-DC and OC-DC Vaccine in High Grade Serous Ovarian Carcinoma
PHASE1Single center, phase I/II randomized 2-arm study, evaluating two different ...
Location
Multiple Locations
Dendritic Cell Based Therapy of Malignant Melanoma
PHASE1The aim of the study is to show if vaccination with autologous dendritic ce...
Location
Department of Oncology, Copenhagen University Hospital, Herlev
Autologous Dendritic Cells Pulsed With Tumor Lysate Antigen Vaccine and Nivolumab in Treating Patients With Recurrent Glioblastoma
PHASE2This phase II trial studies the side effects of autologous dendritic cells ...
Location
UCLA / Jonsson Comprehensive Cancer Center
Dendritic Cell Based Therapy of Renal Cell Carcinoma
PHASE1The purpose of this study is to show if vaccination with autologous dendrit...
Location
Department of Oncology, Copenhagen University Hospital, Herlev
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
PHASE3The primary purpose of the study is to determine the efficacy of an investi...
Location
University of Alabama at Birmingham
Dendritic Cell Vaccine for Patients With Brain Tumors
PHASE2The main purpose of this study is to evaluate the most effective immunother...
Location
University of Los Angeles, California
A Translational Study of Tumor Antigen-pulsed DC Vaccine for ESCC
PHASE1The aim of this single center, single arm and prospective study is to explo...
Location
West China Hospital